Stock Market News

2 months Neurocrine Crumbles On Lackluster Guidance For Its Bread-And-Butter Drug Investor's Business Daily

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
The post Neurocrine Crumbles On Lackluster Guidance For Its Bread-And-Butter Drug appeared first on Investor's Business Daily.

Biotech Business

56 minutes Beverage billionaire dismisses silly corporate titles TheStreet

2 hours High Stakes and Lack of Details Add to Jitters About Trump Tariffs The New York Times

2 hours Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1 Investor's Business Daily

2 hours Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr. Zacks

3 hours Trump Aids Draft Tariffs Plans as Some Experts Warn of Economic Damage Reddit

3 hours 3 years into war with Russia, this Ukrainian startup is powering a drone revolution Fast Company

4 hours Intel: Stuck With Its Foundry Business And The Losses That Come With It Seeking Alpha

4 hours Northvolt cuts workforce to 1,700 as part of bankruptcy process Fortune

5 hours Trump’s 25% Tariff On Imported Vehicles Could Shatter Detroit’s Auto Economy, Warns Business Leaders: ‘It Will Hurt Hardworking Americans’ Reddit

6 hours Tesla car sales in France, Sweden drop to lowest first-quarter in four years Reddit

13 hours Trump’s auto tariffs will lead to autoworker pain, two Michigan business groups say Investing.com

14 hours Japan’s Large Manufacturing Index eases to 12.0 in the first quarter (Q1) of 2025 – Tankan survey FXStreet

15 hours Stocks close mixed despite tariff jitters, biotech stocks under pressure, US debt downgrade risks YouTube

15 hours Trump 25% auto tariffs will lead to vehicle price hikes, autoworker pain, two Michigan business groups say Investing.com

15 hours Symbotic Inc. (SYM) Gains But Lags Market: What You Should Know Zacks

16 hours Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates Zacks

17 hours S&P 500 Had Worst Quarter In Years Amid Trump Tariffs As Gold Shined Investor's Business Daily

17 hours MBAs are launching venture capital funds to back their classmates. Now, Harvard Business School has one, too. Business Insider

18 hours I flew on 2 long-haul flights, one in business and another in economy. The meal service couldn’t have been more different. Business Insider

18 hours Sabra Healthcare REIT Stock Gets RS Rating Upgrade Investor's Business Daily

18 hours Stryker Stock Gets Relative Strength Rating Lift Investor's Business Daily

18 hours Is Your Business Struggling? Take These Steps to Drive Your Company to Success Entrepreneur

19 hours W.R. Berkley Joins Elite Club Of Stocks With RS Ratings Over 90 Investor's Business Daily

19 hours Bad Clients Can Derail Your Business. Here’s How to Fire Them the Right Way. Entrepreneur

20 hours Netflix Viewership Gets Late Q1 Lift From Hit Show ‘Adolescence’ Investor's Business Daily

Read more news +

The Stock Market News

The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.